219 related articles for article (PubMed ID: 22952942)
21. Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell lines.
Elahian F; Kalalinia F; Behravan J
Drug Chem Toxicol; 2010 Apr; 33(2):113-9. PubMed ID: 20307139
[TBL] [Abstract][Full Text] [Related]
22. Role of JNK and p38 MAPK in Taiwanin A-induced cell death.
Ho PJ; Chou CK; Yeh SF
Life Sci; 2012 Dec; 91(25-26):1358-65. PubMed ID: 23123629
[TBL] [Abstract][Full Text] [Related]
23. miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells.
Wang Y; Zhao L; Xiao Q; Jiang L; He M; Bai X; Ma M; Jiao X; Wei M
Gynecol Oncol; 2016 Jun; 141(3):592-601. PubMed ID: 26644266
[TBL] [Abstract][Full Text] [Related]
24. The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells.
Yao C; Du W; Chen H; Xiao S; Huang L; Chen F
Leuk Lymphoma; 2015 Mar; 56(3):755-62. PubMed ID: 24996439
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP).
Meyer zu Schwabedissen HE; Grube M; Dreisbach A; Jedlitschky G; Meissner K; Linnemann K; Fusch C; Ritter CA; Völker U; Kroemer HK
Drug Metab Dispos; 2006 Apr; 34(4):524-33. PubMed ID: 16415123
[TBL] [Abstract][Full Text] [Related]
26. Involvement of stress activated protein kinases (JNK and p38) in 1,25 dihydroxyvitamin D3-induced breast cell death.
Brosseau CM; Pirianov G; Colston KW
Steroids; 2010 Dec; 75(13-14):1082-8. PubMed ID: 20654640
[TBL] [Abstract][Full Text] [Related]
27. Bag-1 silencing enhanced chemotherapeutic drug-induced apoptosis in MCF-7 breast cancer cells affecting PI3K/Akt/mTOR and MAPK signaling pathways.
Kilbas PO; Akcay IM; Doganay GD; Arisan ED
Mol Biol Rep; 2019 Feb; 46(1):847-860. PubMed ID: 30661182
[TBL] [Abstract][Full Text] [Related]
28. Glucosamine attenuates drug resistance in Mitoxantrone-resistance breast cancer cells.
Valinezhad Sani F; Palizban A; Mosaffa F; Jamialahmadi K
J Pharm Pharmacol; 2021 Jun; 73(7):922-927. PubMed ID: 33885909
[TBL] [Abstract][Full Text] [Related]
29. Plastin 3 down-regulation augments the sensitivity of MDA-MB-231 cells to paclitaxel via the p38 MAPK signalling pathway.
Ma Y; Lai W; Zhao M; Yue C; Shi F; Li R; Hu Z
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):685-695. PubMed ID: 30829071
[TBL] [Abstract][Full Text] [Related]
30. Variation in cisplatinum sensitivity is not associated with Fanconi Anemia/BRCA pathway inactivation in head and neck squamous cell carcinoma cell lines.
Snyder ER; Ricker JL; Chen Z; Waes CV
Cancer Lett; 2007 Jan; 245(1-2):75-80. PubMed ID: 16466850
[TBL] [Abstract][Full Text] [Related]
31. Physical and functional crosstalk between Fanconi anemia core components and the GINS replication complex.
Tumini E; Plevani P; Muzi-Falconi M; Marini F
DNA Repair (Amst); 2011 Feb; 10(2):149-58. PubMed ID: 21109493
[TBL] [Abstract][Full Text] [Related]
32. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.
Moes-Sosnowska J; Rzepecka IK; Chodzynska J; Dansonka-Mieszkowska A; Szafron LM; Balabas A; Lotocka R; Sobiczewski P; Kupryjanczyk J
Cancer Biol Ther; 2019; 20(6):843-854. PubMed ID: 30822218
[TBL] [Abstract][Full Text] [Related]
33. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.
Wood RA; Barbour MJ; Gould GW; Cunningham MR; Plevin RJ
Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417765
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor.
Rego MA; Harney JA; Mauro M; Shen M; Howlett NG
Oncogene; 2012 Jan; 31(3):366-75. PubMed ID: 21685936
[TBL] [Abstract][Full Text] [Related]
35. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
36. Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQ.
Chen D; Wang W; Qin JJ; Wang MH; Murugesan S; Nadkarni DH; Velu SE; Wang H; Zhang R
Curr Cancer Drug Targets; 2013 Jul; 13(6):651-60. PubMed ID: 23607596
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer.
Shi R; Wang C; Fu N; Liu L; Zhu D; Wei Z; Zhang H; Xing J; Wang Y
Oncol Rep; 2019 May; 41(5):3015-3026. PubMed ID: 30896886
[TBL] [Abstract][Full Text] [Related]
38. Protodioscin Induces Apoptosis Through ROS-Mediated Endoplasmic Reticulum Stress via the JNK/p38 Activation Pathways in Human Cervical Cancer Cells.
Lin CL; Lee CH; Chen CM; Cheng CW; Chen PN; Ying TH; Hsieh YH
Cell Physiol Biochem; 2018; 46(1):322-334. PubMed ID: 29590661
[TBL] [Abstract][Full Text] [Related]
39. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
Hsu YL; Kuo PL; Lin LT; Lin CC
J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells.
Chen L; Mayer JA; Krisko TI; Speers CW; Wang T; Hilsenbeck SG; Brown PH
Cancer Res; 2009 Dec; 69(23):8853-61. PubMed ID: 19920204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]